Mingyu Pan,Tongyu Hu,Jiao Lyu,Yue Yin,Jing Sun,Quanyi Wang,Lingxiao Xu,Haiyang Hu,Chen Wang,Mingyu PanTongyu HuJiao LyuYue YinJing SunQuanyi WangLingxiao XuHaiyang HuChen Wanga State Key Laboratory of Natural Medicines,School of Life Science and Technology,China Pharmaceutical University,Nanjing,Jiangsu,Chinab Department of Biomedical Science,City University of Hong Kong,Hong Kong,Hong Kong,Chinac Department of Rheumatology,The affiliated Suqian First People's Hospital of Nanjing Medical University,Suqian,Jiangsu,Chinad Department of Rheumatology,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu,China

Abstract:STING1 (stimulator of interferon response cGAMP interactor 1) is the quintessential protein in the CGAS-STING1 signaling pathway, crucial for the induction of type I IFN (interferon) production and eliciting innate immunity. Nevertheless, the overactivation or sustained activation of STING1 has been closely associated with the onset of autoimmune disorders. Notably, the majority of these disorders manifest as an upregulated expression of type I interferons and IFN-stimulated genes (ISGs). Hence, strict regulation of STING1 activity is paramount to preserve immune homeostasis. Here, we reported that CSNK1A1/CK1α, a serine/threonine protein kinase, was essential to prevent the overactivation of STING1-mediated type I IFN signaling through autophagic degradation of STING1. Mechanistically, CSNK1A1 interacted with STING1 upon the CGAS-STING1 pathway activation and promoted STING1 autophagic degradation by enhancing the phosphorylation of SQSTM1/p62 at serine 351 (serine 349 in human), which was critical for SQSTM1-mediated STING1 autophagic degradation. Consistently, SSTC3, a selective CSNK1A1 agonist, significantly attenuated the response of the CGAS-STING1 signaling by promoting STING1 autophagic degradation. Importantly, pharmacological activation of CSNK1A1 using SSTC3 markedly repressed the systemic autoinflammatory responses in the trex1 -/- mouse autoimmune disease model and effectively suppressed the production of IFNs and ISGs in the PBMCs of SLE patients. Taken together, our study reveals a novel regulatory role of CSNK1A1 in the autophagic degradation of STING1 to maintain immune homeostasis. Manipulating CSNK1A1 through SSTC3 might be a potential therapeutic strategy for alleviating STING1-mediated aberrant type I IFNs in autoimmune diseases. Abbreviations: BMDMs: bone marrow-derived macrophages; cGAMP: cyclic GMP-AMP; CGAS: cyclic GMP-AMP synthase; HTDNA: herring testes DNA; IFIT1: interferon induced protein with tetratricopeptide repeats 1; IFNA4: interferon alpha 4; IFNB: interferon beta; IRF3: interferon regulatory factor 3; ISD: interferon stimulatory DNA; ISGs: IFN-stimulated genes; MEFs: mouse embryonic fibroblasts; PBMCs: peripheral blood mononuclear cells; RSAD2: radical S-adenosyl methionine domain containing 2; SLE: systemic lupus erythematosus; STING1: stimulator of interferon response cGAMP interactor 1; TBK1: TANK binding kinase 1.

cGAS-activated endothelial cell–T cell cross-talk initiates tertiary lymphoid structure formation

cGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Cellular functions of cGAS-STING signaling

cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model

Cardiomyocytic cGAS is critical for the induction of experimental cardiac graft rejection

Updated roles of cGAS-STING signaling in autoimmune diseases

Harnessing cGAS-STING axis for therapeutic benefits in systemic lupus erythematosus

Small molecules targeting cGAS-STING pathway for autoimmune disease

Activated STING in the thymus alters T cell development and selection leading to autoimmunity

CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

Therapeutic landscape in systemic lupus erythematosus: mtDNA activation of the cGAS-STING pathway

Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases

cGAS Expression is Enhanced in Systemic Sclerosis Associated Interstitial Lung Disease and Stimulates Inflammatory Myofibroblast Activation

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation

Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection

Suppression of systemic autoimmunity by the innate immune adaptor STING

Autophagy receptor CCDC50 tunes the STING-mediated interferon response in viral infections and autoimmune diseases

Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitis